XML 45 R28.htm IDEA: XBRL DOCUMENT v3.26.1

LICENSE REVENUE (Tables)

12 Months Ended

Dec. 31, 2025

Collaborative Arrangement and Arrangement Other than Collaborative [Abstract]

Schedule of License and Grant Revenue

The following table summarizes the total revenue recorded in the Company’s consolidated statements of operations (in thousands):

			YEAR ENDED DECEMBER 31,
			2025						2024
License fee revenue
Scithera, Inc.			$	1,300					$	—
Regeneron Pharmaceuticals, Inc.			—						200
Total license fee revenue			$	1,300					$	200

X

- Definition

Collaborative Arrangement and Arrangement Other than Collaborative

+ References

No definition available.

+ Details

Name:	inbx_CollaborativeArrangementAndArrangementOtherThanCollaborativeAbstract
Namespace Prefix:	inbx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule Of License And Grant Revenue

+ References

No definition available.

+ Details

Name:	inbx_ScheduleOfLicenseAndGrantRevenueTableTextBlock
Namespace Prefix:	inbx_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration